Is SOL S.p.A. a good investment? SOL S.p.A. (SOL.MI) is currently trading at 58.50 EUR. Market analysts have a consensus price target of 59.38 EUR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 32.12. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: SOL S.p.A. is expected to release its next earnings report on Sept. 3, 2026. The market consensus estimate for Forward EPS is 2.20.
For income investors, SOL S.p.A. pays a dividend yield of 0.67%. With a payout ratio of 21%, the dividend appears sustainable.
Yes, it pays an annual dividend of 0.39 EUR (0.67% yield).
SOL S.p.A. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
The next earnings date is projected to be Sept. 3, 2026. The company currently has a trailing EPS of 1.84.
SOL S.p.A. produces and distributes technical and medical gases for industry and healthcare facilities in Italy and internationally. The company supplies technical gases, equipment, systems, and services for the industrial sectors; and produces and distributes gases, such as oxygen, nitrogen, argon, hydrogen, carbon dioxide, sulphur dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, gaseous helium, liquid helium, gases for electronics, ammonia, combustible gases for industrial use, and liquefied natural gas. It also provides medical gases with AIC and medical devices, training services, electromedical equipment services, hospital hygiene and environmental monitoring, ambulance management, design and development of biobanks, and InfoHealth solutions; and respiratory and infusion therapies, healthcare and social care services, telemedicine and digital services, and healthcare aids. In addition, the company offers CRYOLAB for transfer, storage and handling services of biological samples; DIATHEVA, which focuses on research, development, production, and marketing products, including monoclonal antibodies, recombinant proteins, and molecular kits for hospital research, diagnosis and clinical application, environmental, veterinary, and food; and PERSONAL GENOMICS for preventive and precision medicine. SOL S.p.A. was founded in 1927 and is headquartered in Monza, Italy. SOL S.p.A. operates as a subsidiary of Gas And Technologies World B.V.
0.67% (5y avg: 1.09%)
0.39 EUR
May 18, 2026
21.27%
| Year | Total Dividends |
|---|---|
| 2026 | 0.45 EUR |
| May 20, 2026 | 0.4510 |
| 2025 | 0.39 EUR |
| May 21, 2025 | 0.3900 |
| 2024 | 0.37 EUR |
| May 22, 2024 | 0.3700 |
| 2023 | 0.33 EUR |
| May 24, 2023 | 0.3300 |
| 2022 | 0.24 EUR |
| May 18, 2022 | 0.2400 |
| 2021 | 0.22 EUR |
| May 26, 2021 | 0.2200 |
| 2020 | 0.18 EUR |
| May 27, 2020 | 0.1750 |
| 2019 | 0.18 EUR |
| May 22, 2019 | 0.1750 |
| 2018 | 0.15 EUR |
| May 23, 2018 | 0.1500 |
| 2017 | 0.15 EUR |
| May 24, 2017 | 0.1500 |
| 2016 | 0.12 EUR |
| May 23, 2016 | 0.1200 |
| 2015 | 0.11 EUR |
| May 18, 2015 | 0.1100 |
| 2014 | 0.10 EUR |
| May 19, 2014 | 0.1000 |
| 2013 | 0.10 EUR |
| May 20, 2013 | 0.1000 |
| 2012 | 0.10 EUR |
| May 21, 2012 | 0.1000 |
| 2011 | 0.10 EUR |
| May 23, 2011 | 0.0950 |
| 2010 | 0.08 EUR |
| May 17, 2010 | 0.0840 |
| 2009 | 0.08 EUR |
| May 11, 2009 | 0.0810 |
| 2008 | 0.08 EUR |
| May 12, 2008 | 0.0810 |
| 2007 | 0.07 EUR |
| May 14, 2007 | 0.0680 |
| 2006 | 0.07 EUR |
| May 15, 2006 | 0.0670 |
| 2005 | 0.07 EUR |
| May 16, 2005 | 0.0670 |
| 2004 | 0.06 EUR |
| May 17, 2004 | 0.0610 |
| 2003 | 0.06 EUR |
| May 19, 2003 | 0.0610 |
| 2002 | 0.05 EUR |
| May 20, 2002 | 0.0543 |
| 2001 | 0.05 EUR |
| May 21, 2001 | 0.0546 |
| 2000 | 0.05 EUR |
| May 22, 2000 | 0.0468 |
| 1999 | 0.04 EUR |
| May 24, 1999 | 0.0390 |
Yearly aggregated dividends
|
SOL S.p.A.
May 20, 2026 Upcoming
Dividend
0.451 EUR |
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion